List of Tables
Table 1. Global Oral Vaccines Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Oral Vaccines Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Oral Vaccines Market Competitive Situation by Manufacturers in 2025
Table 4. Global Oral Vaccines Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Oral Vaccines Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Oral Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Oral Vaccines Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Oral Vaccines Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Oral Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Oral Vaccines, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Oral Vaccines, Product Types and Applications
Table 12. Global Key Manufacturers of Oral Vaccines, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Oral Vaccines Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Oral Vaccines Sales by Region (K Dose), 2021–2026
Table 18. Global Oral Vaccines Sales Market Share by Region (2021–2026)
Table 19. Global Oral Vaccines Sales by Region (K Dose), 2027–2032
Table 20. Global Oral Vaccines Sales Market Share by Region (2027–2032)
Table 21. Global Oral Vaccines Revenue by Region (US$ Million), 2021–2026
Table 22. Global Oral Vaccines Revenue Market Share by Region (2021–2026)
Table 23. Global Oral Vaccines Revenue by Region (US$ Million), 2027–2032
Table 24. Global Oral Vaccines Revenue Market Share by Region (2027–2032)
Table 25. North America Oral Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Oral Vaccines Sales by Country (K Dose), 2021–2026
Table 27. North America Oral Vaccines Sales by Country (K Dose), 2027–2032
Table 28. North America Oral Vaccines Revenue by Country (US$ Million), 2021–2026
Table 29. North America Oral Vaccines Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Oral Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Oral Vaccines Sales by Country (K Dose), 2021–2026
Table 32. Europe Oral Vaccines Sales by Country (K Dose), 2027–2032
Table 33. Europe Oral Vaccines Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Oral Vaccines Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Oral Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Oral Vaccines Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Oral Vaccines Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Oral Vaccines Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Oral Vaccines Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Oral Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Oral Vaccines Sales by Country (K Dose), 2021–2026
Table 42. Latin America Oral Vaccines Sales by Country (K Dose), 2027–2032
Table 43. Latin America Oral Vaccines Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Oral Vaccines Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Oral Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Oral Vaccines Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Oral Vaccines Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Oral Vaccines Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Oral Vaccines Revenue by Country (US$ Million), 2027–2032
Table 50. Global Oral Vaccines Sales (K Dose) by Type (2021–2026)
Table 51. Global Oral Vaccines Sales (K Dose) by Type (2027–2032)
Table 52. Global Oral Vaccines Sales Market Share by Type (2021–2026)
Table 53. Global Oral Vaccines Sales Market Share by Type (2027–2032)
Table 54. Global Oral Vaccines Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Oral Vaccines Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Oral Vaccines Revenue Market Share by Type (2021–2026)
Table 57. Global Oral Vaccines Revenue Market Share by Type (2027–2032)
Table 58. Global Oral Vaccines Price (US$/Dose) by Type (2021–2026)
Table 59. Global Oral Vaccines Price (US$/Dose) by Type (2027–2032)
Table 60. Global Oral Vaccines Sales (K Dose) by Application (2021–2026)
Table 61. Global Oral Vaccines Sales (K Dose) by Application (2027–2032)
Table 62. Global Oral Vaccines Sales Market Share by Application (2021–2026)
Table 63. Global Oral Vaccines Sales Market Share by Application (2027–2032)
Table 64. Global Oral Vaccines Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Oral Vaccines Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Oral Vaccines Revenue Market Share by Application (2021–2026)
Table 67. Global Oral Vaccines Revenue Market Share by Application (2027–2032)
Table 68. Global Oral Vaccines Price (US$/Dose) by Application (2021–2026)
Table 69. Global Oral Vaccines Price (US$/Dose) by Application (2027–2032)
Table 70. Merck Company Information
Table 71. Merck Description and Business Overview
Table 72. Merck Oral Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Merck Oral Vaccines Product
Table 74. Merck Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Oral Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. GSK Oral Vaccines Product
Table 79. GSK Recent Developments/Updates
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Oral Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Sanofi Oral Vaccines Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Lanzhou Institute Company Information
Table 86. Lanzhou Institute Description and Business Overview
Table 87. Lanzhou Institute Oral Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Lanzhou Institute Oral Vaccines Product
Table 89. Lanzhou Institute Recent Developments/Updates
Table 90. Serum Institute Company Information
Table 91. Serum Institute Description and Business Overview
Table 92. Serum Institute Oral Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Serum Institute Oral Vaccines Product
Table 94. Serum Institute Recent Developments/Updates
Table 95. Valneva Company Information
Table 96. Valneva Description and Business Overview
Table 97. Valneva Oral Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Valneva Oral Vaccines Product
Table 99. Valneva Recent Developments/Updates
Table 100. Shanghai United Cell Company Information
Table 101. Shanghai United Cell Description and Business Overview
Table 102. Shanghai United Cell Oral Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Shanghai United Cell Oral Vaccines Product
Table 104. Shanghai United Cell Recent Developments/Updates
Table 105. Bibcol Company Information
Table 106. Bibcol Description and Business Overview
Table 107. Bibcol Oral Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. Bibcol Oral Vaccines Product
Table 109. Bibcol Recent Developments/Updates
Table 110. PaxVax Company Information
Table 111. PaxVax Description and Business Overview
Table 112. PaxVax Oral Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. PaxVax Oral Vaccines Product
Table 114. PaxVax Recent Developments/Updates
Table 115. Vabiotech Company Information
Table 116. Vabiotech Description and Business Overview
Table 117. Vabiotech Oral Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 118. Vabiotech Oral Vaccines Product
Table 119. Vabiotech Recent Developments/Updates
Table 120. Tiantan Biological Company Information
Table 121. Tiantan Biological Description and Business Overview
Table 122. Tiantan Biological Oral Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 123. Tiantan Biological Oral Vaccines Product
Table 124. Tiantan Biological Recent Developments/Updates
Table 125. EuBiologics Company Information
Table 126. EuBiologics Description and Business Overview
Table 127. EuBiologics Oral Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 128. EuBiologics Oral Vaccines Product
Table 129. EuBiologics Recent Developments/Updates
Table 130. Panacea Biotec Ltd Company Information
Table 131. Panacea Biotec Ltd Description and Business Overview
Table 132. Panacea Biotec Ltd Oral Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 133. Panacea Biotec Ltd Oral Vaccines Product
Table 134. Panacea Biotec Ltd Recent Developments/Updates
Table 135. Bio-Med Company Information
Table 136. Bio-Med Description and Business Overview
Table 137. Bio-Med Oral Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 138. Bio-Med Oral Vaccines Product
Table 139. Bio-Med Recent Developments/Updates
Table 140. Halfkin Bio-Pharmaceuticals Company Information
Table 141. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 142. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 143. Halfkin Bio-Pharmaceuticals Oral Vaccines Product
Table 144. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 145. CNBG Company Information
Table 146. CNBG Description and Business Overview
Table 147. CNBG Oral Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 148. CNBG Oral Vaccines Product
Table 149. CNBG Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Oral Vaccines Distributors List
Table 153. Oral Vaccines Customers List
Table 154. Oral Vaccines Market Trends
Table 155. Oral Vaccines Market Drivers
Table 156. Oral Vaccines Market Challenges
Table 157. Oral Vaccines Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Oral Vaccines
Figure 2. Global Oral Vaccines Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Oral Vaccines Market Share by Type: 2025 & 2032
Figure 4. Rotavirus Vaccine Product Picture
Figure 5. Cholera Vaccine Product Picture
Figure 6. Oral Polio Vaccine Product Picture
Figure 7. Other Product Picture
Figure 8. Global Oral Vaccines Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Oral Vaccines Market Share by Application: 2025 & 2032
Figure 10. Public
Figure 11. Private
Figure 12. Global Oral Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Oral Vaccines Market Size (US$ Million), 2021–2032
Figure 14. Global Oral Vaccines Sales (K Dose), 2021–2032
Figure 15. Global Oral Vaccines Average Price (US$/Dose), 2021–2032
Figure 16. Oral Vaccines Report Years Considered
Figure 17. Oral Vaccines Sales Share by Manufacturers in 2025
Figure 18. Global Oral Vaccines Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Oral Vaccines Players: Market Share by Revenue in Oral Vaccines in 2025
Figure 20. Oral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Oral Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Oral Vaccines Sales Market Share by Country (2021–2032)
Figure 23. North America Oral Vaccines Revenue Market Share by Country (2021–2032)
Figure 24. U.S. Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Oral Vaccines Sales Market Share by Country (2021–2032)
Figure 27. Europe Oral Vaccines Revenue Market Share by Country (2021–2032)
Figure 28. Germany Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Oral Vaccines Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Oral Vaccines Revenue Market Share by Region (2021–2032)
Figure 35. China Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Taiwan Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Indonesia Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Thailand Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Malaysia Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Philippines Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Oral Vaccines Sales Market Share by Country (2021–2032)
Figure 46. Latin America Oral Vaccines Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Oral Vaccines Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Oral Vaccines Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. U.A.E Oral Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Oral Vaccines by Type (2021–2032)
Figure 56. Global Revenue Market Share of Oral Vaccines by Type (2021–2032)
Figure 57. Global Oral Vaccines Price (US$/Dose) by Type (2021–2032)
Figure 58. Global Sales Market Share of Oral Vaccines by Application (2021–2032)
Figure 59. Global Revenue Market Share of Oral Vaccines by Application (2021–2032)
Figure 60. Global Oral Vaccines Price (US$/Dose) by Application (2021–2032)
Figure 61. Oral Vaccines Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
